Avadel Pharmaceuticals Plc (AVDL) Return on Assets ROA from the third quarter of 2025 to third quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Sep 30 2025 to Sep 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Avadel Pharmaceuticals Plc  (NASDAQ: AVDL)


Avadel Pharmaceuticals Plc's ROA from the third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Avadel Pharmaceuticals Plc's ROA in the third quarter of 2025?
Avadel Pharmaceuticals Plc recorded a cumulative net loss of $0 million during 12 months ending in the third quarter of 2025, resulting in a negative return on assets (ROA) of -0.14%.

However, within the Healthcare sector 215 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2025 quarter, so far to 2589, from total ROA ranking in the second quarter of 2025 at 2796.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Total Assets Change 74.86 % 73.59 % 51.61 % 134 % 26.59 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 0 -3 -26 -49 -80
Return On Assets (TTM) -0.14 % -1.66 % -16.95 % -34.51 % -74.06 %
AVDL's Total Ranking # 2589 # 2796 # 3530 # 4456 # 4208
Total Assets (TTM) in million 199 187 168 233 114
Seq. Total Assets Change 6.57 % 11.44 % -28.04 % 104.62 % 5.79 %
Seq. Net Income Change -99.79 % - - - -

AVDL's 5 Years Annual ROA >> Back to AVDL Management Effectiveness >> Compare AVDL ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 74
Sector # 216
Overall # 2561

Return On Assets Statistics
High Average Low
8.46 %
-38.39 %
-98.28 %
(Jun 30 2020)   (Mar 31 2023)



  News about Avadel Pharmaceuticals Plc Return on Assets ROA

Avadel Pharmaceuticals Seeks Revival Amid Financial Struggles: New VP of Sales and Inducement Awards Signal Shift in Strategy

Avadel Pharmaceuticals Seeks Revival Amid Financial Struggles: New VP of Sales and Inducement Awards Signal Shift in Strategy DUBLIN, Feb. 24, 2025 – In a swift response to financial pressures, Avadel Pharmaceuticals plc (Nasdaq: AVDL) has announced the appointment of Kevin Springman as Vice President of Sales, aiming to revitalize its commercial strategy amidst a backdrop of significant net losses and underwhelming return on assets (ROA).Previously, Avadel recorded a staggering cumulative net loss of $80 million over the past year, leading to an alarming -46.63% ROA and placing the company at a disadvantage among its peers in the healthcare sector. While 562 healthcare companies demonstrated stronger financial performance, Avadel s struggles stand out, amplifying investor concerns as the company tries to navigate through turbulent waters.



Financial Statements
Avadel Pharmaceuticals Plc's Assets $ 199 million AVDL's Balance sheet
Avadel Pharmaceuticals Plc's Income $ 0 million Quarterly AVDL's Income Statement
AVDL's Income by Division See AVDL's Income by Division



Annual Return On Assets (Dec 31 2024)
FY 2024		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019
Y / Y Total Assets Change 28.56 % -17.53 % -1.62 % 56.9 % -16.11 %
Total Assets in million 233 182 220 224 143
Y / Y Net Income Change - - - - -
Net Income in million -49 -137 -77 7 -33
Annual Return On Assets -20.92 % -75.72 % -35.13 % 3.14 % -23.3 %

AVDL's 5 Years Annual ROA >> Back to AVDL Management Effectiveness >> Compare AVDL ROA to its Competitors



More Return On Assets Ratios
AVDL's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
AVDL's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for AVDL's Competitors
Subscribers only: Roa for Avadel Pharmaceuticals Plc's Suppliers
Subscribers only: Return On Assets for AVDL's Customers

You may also want to know
AVDL's Roi AVDL's Inventory Turnover Ratio AVDL's Growth Rates AVDL's Dividend Comparisons
AVDL's Profitability Ratios AVDL's Asset Turnover Ratio AVDL's Dividend Growth
AVDL's Roe AVDL's Valuation Ratios AVDL's Financial Strength Ratios AVDL's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2025, within Healthcare Sector ROA

Date modified: 2026-09-18T14:07:35+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.